# Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients

> **NCT06708754** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 60 (estimated)

## Conditions studied

- Radiation Lymphedema
- Radiation Fibrosis
- Head and Neck Cancer

## Interventions

- **DEVICE:** Photobiomodulation (PBM) Therapy
- **DEVICE:** Sham PBM

## Key facts

- **NCT ID:** NCT06708754
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-13
- **Primary completion:** 2028-02-13
- **Final completion:** 2030-02-13
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708754, "Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06708754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*